Skip to main content
. 2014 Mar 10;25(4):808–815. doi: 10.1093/annonc/mdu009

Figure 1.

Figure 1.

Figure 1.

Cumulative risk estimates for initial onset of grade ≥2 (A) stomatitis, (B) pneumonitis, (C) hyperglycemia/new-onset diabetes mellitus, and (D) fatigue. EVE, everolimus; EXE, exemestane; PBO, placebo.